genedx.com - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi WGS
High levels of robotics and AI implementation are optimizing genome analysis, which is reflected in the monetary expression of EBITDA. The value of 0.00 indicates the level of this parameter. The business relies on non-cyclical demand for diagnostics, which remains resilient during crises. Currently, GeneDx Holdings Corp. is prioritizing organic growth and scientific alliances, temporarily pivoting away from aggressive mergers to focus on profitability.
GeneDx Holdings Corp. (WGS) - rincian metrik lan laporan keuangan
- rega saham lan prakiraan rega para ahli:
- rincian nilai pasar emiten:
- informasi kapitalisasi buku:
- rincian struktur utang lan likuiditas bisnis:
Utang marang Ekuitas GeneDx Holdings Corp.|WGS - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang modal Sema4|WGS - Gunggung utang perusahaan|Utang-utang marang aset resik GeneDx Holdings Corp.|WGS - Utang jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan GeneDx|Likuiditas kritis genedx.com
- statistik bathi lan rasio pasar:
WGS - Bathi resik perusahaan|Prakiraan bathi perusahaan GeneDx Holdings Corp.|WGS - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi GeneDx|WGS - Pangali PEG|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan GeneDx Holdings Corp.|WGS - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben siji saham sajrone rolas wulan pungkasan GeneDx|WGS - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan genedx.com|WGS - Wutah bathi saben saham ing taun lumaku|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep GeneDx Holdings Corp.
- data dodolan lan asil:
Ringkesan analitik perusahaan:WGS genedx.com
It is critical for investors to mitigate the risk of overpaying for an asset by analyzing the absolute EBITDA level to determine the real cash flow from core operations, which measures the business's ability to generate cash before depreciation and taxes. Explosive demand for genomic sequencing is accelerating the ARR of GeneDx Holdings Corp. (WGS), transforming operational resilience into a foundation for profitability and confirming the high reliability of the business model.
Pesaing GeneDx Holdings Corp. (WGS)
Pendapatan operasional sadurunge ngurangi amortisasi Tempus AI Inc (TEM)|QGEN - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi IONS (Ionis Pharmaceuticals, Inc.)|RGEN: Bathi operasional EBITDA|Avidity - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional sadurunge ngurangi amortisasi CRSP|Bathi operasional sadurunge amortisasi RARE (Ultragenyx)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Beam Therapeutics (BEAM)|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi SRPT|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Twist Bioscience Corp TWST|Pendapatan operasional sadurunge ngurangi amortisasi 10x Genomics, Inc. (TXG)|Intellia Therapeutics - Bathi operasional EBITDA|STOK - Bathi operasional EBITDA|BLFS (biolifesolutions.com) - Bathi operasional sadurunge ngurangi amortisasi|WVE - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional sadurunge ngurangi amortisasi MAZE|Sionna Pharma - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi operasional EBITDA PRME|TSHA (Taysha Gene Therapies) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi uniQure QURE|MGTX: Bathi operasional sadurunge amortisasi|REGENXBIO Inc - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Solid Corp|Ocugen (OCGN) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge ngurangi amortisasi Pacific Biosciences|Bathi operasional sadurunge ngurangi amortisasi BNTC|Bathi operasional sadurunge ngurangi amortisasi Design Therapeutics Inc (DSGN)|Bathi operasional EBITDA RCKT|Bathi operasional EBITDA 4D Molecular Therapeutics, Inc. (FDMT)|lexeotx.com - Bathi operasional sadurunge ngurangi amortisasi|KRRO: Bathi operasional sadurunge amortisasi|Editas Corp - Bathi operasional EBITDA|SLN: Bathi sadurunge mbayar bunga, pajak, lan amortisasi|PRQR (ProQR) - Bathi operasional sadurunge ngurangi amortisasi|Bathi operasional sadurunge amortisasi CDXS|Bathi sadurunge mbayar bunga, pajak, lan amortisasi sangamo.com|Bathi operasional sadurunge amortisasi NAUT (Nautilus Biotechnology)|Bathi operasional EBITDA MGX|Pendapatan operasional sadurunge ngurangi amortisasi Precision BioSciences Inc.|Bathi operasional EBITDA GBIO (Generation Bio Co)|Bathi operasional EBITDA Boundless Bio, Inc BOLD|Exicure Corp - Bathi operasional EBITDA|Pendapatan operasional sadurunge ngurangi amortisasi Imunon IMNN|PHIO: Bathi operasional EBITDA|MBIO: Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi TransCode Therapeutics, Inc.|Bathi operasional EBITDA Bionano Genomics, Inc.|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Applied DNA (APDN)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi BLUE (bluebird bio, Inc.)|Bathi operasional EBITDA IPA (immunoprecise.com)|Bathi operasional EBITDA Omega OMGA|OMIC - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|RGLS - Bathi operasional EBITDA|Syros Pharmaceuticals Inc. (SYRS) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|TBIO (Telesis Bio, Inc.) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|TCON (TRACON Pharmaceuticals Inc.) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Unity Bio UBX
